4051 — GMO Financial Gate Balance Sheet
0.000.00%
- ¥49bn
- ¥47bn
- ¥19bn
- 79
- 19
- 80
- 66
Annual balance sheet for GMO Financial Gate, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | R2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,946 | 3,434 | 2,519 | 4,017 | 5,074 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 312 | 519 | 628 | 968 | 3,166 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,024 | 5,790 | 5,016 | 7,505 | 11,632 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 58.9 | 60.3 | 79.7 | 94.3 | 214 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6,125 | 7,136 | 6,638 | 9,323 | 14,207 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,047 | 2,720 | 1,929 | 2,665 | 6,234 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,305 | 2,919 | 2,134 | 4,383 | 8,579 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 3,820 | 4,217 | 4,504 | 4,940 | 5,628 |
| Total Liabilities & Shareholders' Equity | 6,125 | 7,136 | 6,638 | 9,323 | 14,207 |
| Total Common Shares Outstanding |